COVID-19 Drugs Banned Despite Efficacy || "It Must Be Part Of A Master Plan"

3 years ago

|

CREDIT:

Show: Outsiders
Video: Sky News Australia
Guest: Dr Peter McCullough
Date: November 28th, 2020

DESCRIPTION:

Dr. Peter Andrew McCullough is an American cardiologist and professor at Texas Christian University & University of North Texas Health Science Center School of Medicine. He is formerly Vice Chief of Internal Medicine at Baylor University Medical Center in Dallas, Texas and professor at Texas A&M University. He is editor-in-chief of the journals Reviews in Cardiovascular Medicine and Cardiorenal Medicine. During the COVID-19 pandemic, Dr. Peter Andrew McCullough advocated for early treatment and dissented from the recommendations of government public health agencies.

Dr. McCullough, in Dallas, explains that HCQ's great ability to save lives from COVID-19 is banned despite it's wonderful efficacy.

Nations across the globe have "completely de-emphasised and almost obfuscated" effective corona-virus treatments in their public health approach to the pandemic, says Professor of Medicine Dr. Peter McCullough.

"There's literally been nothing outside of a public health approach for just wearing masks, staying at home, sheltering in place and waiting for a vaccine," he told Sky News.

“It must be part of a master plan."

“But I have to tell you for people who get sick it doesn't work."

Dr. McCullough declared there was in fact "no controversy over whether or not HydroxyChloroquine (HCQ) works" saying the chances that the drug doesn't work are calculated to be one in 17 billion."

"The controversy is on the public health approach to COVID-19," he said.

"I think historians are going to be very unkind to Australia, Canada, the United States, the UK, western European Union, and some south American countries.

"They are what I call the nihilistic countries. The countries that are offering no home treatment ... and creating such a fearful population right now that is ... hungry for a vaccine to just move on."

Loading comments...